feed,title,long_url,short_url
MarketWatch,Vir's stock gains on early results from clinical trials for its hepatitis B treatment candidate,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/IIVXmSl_wvI/story.aspx,https://on.mktw.net/3qDNicp
